You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RYTM Sale Disclosure
Lee Jennifer Kayden · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$8.9M
Lee Jennifer Kayden EVP, Head Of North America
RYTM
Transaction date
Aug 13, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 1 day later
RYTM daily price context
Close on/before transaction
$116.02
Aug 13, 2026
First close after public filing
$115.44
Aug 17, 2026
30-day return after filing
-11.26%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 75,834 shares @ $117.38
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001649904-26-000009
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$9.9M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. RYTM Current | Sale | Aug 13, 2026 | $8.9M |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Aug 13, 2026 | $850.15K |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Aug 13, 2026 | $0 |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Aug 13, 2026 | $0 |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Aug 13, 2026 | $146.89K |